ProUroCare Medical Inc.
PUMD
$0.00
$0.000.00%
OTC PK
| 09/30/2013 | 06/30/2013 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -29.68% | 15.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.70% | 35.40% | |||
| Operating Income | 39.70% | -35.40% | |||
| Income Before Tax | 28.91% | -16.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.91% | -16.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.91% | -16.63% | |||
| EBIT | 39.70% | -35.40% | |||
| EBITDA | 39.79% | -35.51% | |||
| EPS Basic | 29.17% | -15.99% | |||
| Normalized Basic EPS | 29.53% | -28.45% | |||
| EPS Diluted | 29.17% | -15.99% | |||
| Normalized Diluted EPS | 29.53% | -28.45% | |||
| Average Basic Shares Outstanding | 0.29% | 0.45% | |||
| Average Diluted Shares Outstanding | 0.29% | 0.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||